SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.519
AS - Asia 20.967
EU - Europa 11.218
SA - Sud America 3.335
AF - Africa 420
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 71.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.696
SG - Singapore 7.585
CN - Cina 4.914
BR - Brasile 2.630
VN - Vietnam 2.363
IT - Italia 2.166
DE - Germania 2.093
HK - Hong Kong 1.774
UA - Ucraina 1.768
TR - Turchia 1.289
GB - Regno Unito 1.022
BD - Bangladesh 998
FI - Finlandia 984
FR - Francia 780
RU - Federazione Russa 607
JP - Giappone 555
PL - Polonia 520
SE - Svezia 468
IN - India 387
CA - Canada 367
MX - Messico 339
ID - Indonesia 304
AR - Argentina 255
ZA - Sudafrica 175
NL - Olanda 162
IQ - Iraq 141
EC - Ecuador 115
ES - Italia 104
PK - Pakistan 103
CZ - Repubblica Ceca 97
BE - Belgio 94
CO - Colombia 79
UZ - Uzbekistan 78
AT - Austria 75
VE - Venezuela 74
CL - Cile 73
LT - Lituania 63
MA - Marocco 59
AE - Emirati Arabi Uniti 54
SA - Arabia Saudita 54
MY - Malesia 51
PH - Filippine 48
AU - Australia 47
TN - Tunisia 38
PY - Paraguay 35
KE - Kenya 32
JO - Giordania 30
PE - Perù 30
IL - Israele 29
EG - Egitto 27
IE - Irlanda 26
CH - Svizzera 25
RO - Romania 25
NP - Nepal 23
BO - Bolivia 22
AZ - Azerbaigian 21
DZ - Algeria 21
OM - Oman 21
DO - Repubblica Dominicana 19
TH - Thailandia 19
ET - Etiopia 18
UY - Uruguay 18
AL - Albania 16
JM - Giamaica 16
RS - Serbia 16
KR - Corea 15
KZ - Kazakistan 15
LV - Lettonia 14
TT - Trinidad e Tobago 14
IR - Iran 13
HU - Ungheria 12
PS - Palestinian Territory 12
HN - Honduras 11
CR - Costa Rica 10
EU - Europa 10
LB - Libano 10
HR - Croazia 9
PA - Panama 9
YE - Yemen 9
BB - Barbados 8
BG - Bulgaria 8
DK - Danimarca 8
SI - Slovenia 8
TW - Taiwan 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
KG - Kirghizistan 7
NI - Nicaragua 7
PT - Portogallo 7
BH - Bahrain 6
MD - Moldavia 6
NG - Nigeria 6
PR - Porto Rico 6
GE - Georgia 5
LY - Libia 5
QA - Qatar 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
GR - Grecia 4
ME - Montenegro 4
Totale 71.430
Salva come PNG Salva come JPEG
Città #
Singapore 4.822
Ashburn 4.039
Fairfield 3.017
Woodbridge 2.968
Houston 2.054
San Jose 2.050
Jacksonville 1.866
Hong Kong 1.747
Chandler 1.678
Beijing 1.551
Santa Clara 1.445
Ann Arbor 1.362
Seattle 1.183
Wilmington 1.132
Cambridge 977
Ho Chi Minh City 720
New York 705
Izmir 649
Los Angeles 617
Nanjing 593
Dallas 559
Tokyo 536
Hanoi 519
Warsaw 488
Munich 482
Princeton 480
Lauterbourg 436
Helsinki 408
Council Bluffs 358
San Diego 314
Ferrara 310
Boardman 309
Milan 299
São Paulo 268
Shanghai 224
Mexico City 220
Jakarta 206
Shenyang 190
Buffalo 177
Nanchang 172
Turku 171
Orem 149
London 147
Chicago 143
Dong Ket 132
Hebei 128
Tianjin 120
Rome 118
Toronto 117
Bremen 115
Hefei 115
Montreal 114
Addison 113
Haiphong 111
Da Nang 110
Changsha 101
Chennai 98
Brooklyn 93
Rio de Janeiro 93
Johannesburg 91
Moscow 91
Brussels 90
Denver 88
Falls Church 88
Jiaxing 88
Phoenix 85
Dearborn 83
Frankfurt am Main 82
Bologna 76
Jinan 74
San Francisco 74
Atlanta 72
Zhengzhou 72
Stockholm 71
Mountain View 69
Tashkent 65
Redwood City 63
Biên Hòa 62
Brasília 59
Falkenstein 59
Baghdad 58
Manchester 57
Poplar 57
Guangzhou 56
Norwalk 55
Nuremberg 54
Belo Horizonte 52
The Dalles 52
Brno 51
Lappeenranta 51
Amsterdam 50
Curitiba 50
Boston 49
Hải Dương 48
Kunming 46
Mumbai 46
Naples 46
San Mateo 46
Quito 45
Dhaka 40
Totale 47.029
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 419
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 316
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 295
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 293
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 289
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 287
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 281
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 276
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 275
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 275
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 274
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 274
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 271
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 270
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 269
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 269
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 267
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 267
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 266
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 265
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 264
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 264
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 263
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 262
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 262
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 259
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 257
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 256
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 254
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 251
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 250
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 249
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 249
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 249
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 246
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 244
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 244
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 242
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 241
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 240
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 239
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 232
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 231
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 231
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 230
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 230
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 230
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 229
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 228
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 228
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 227
Delirium in acute promyelocytic leukemia patients: Two case reports 227
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 225
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 224
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 224
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 223
Waldenstrom macroglobulinemia 223
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 222
Early CP CML, Nilotinib 400 mg Twice Daily Frontline: Beyond 3 Years, Results Remain Excellent and Stable (A GIMEMA CML Working Party Trial) 222
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 221
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 221
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs 221
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 220
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 220
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 219
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 218
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 217
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 214
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 214
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 214
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 213
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 213
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 212
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 211
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 209
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 209
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 208
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 208
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 208
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 207
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 207
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 207
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 206
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 205
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 205
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 202
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 202
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 202
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 201
Burkitt’s lymphoma 200
Dendritic cells in acute promyelocytic leukaemia 200
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 199
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 198
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 198
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 197
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 196
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 194
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 194
Totale 23.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 329.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 40.411
Totale 370.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021464 0 0 0 0 0 0 0 0 0 0 0 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20259.403 315 200 787 324 1.145 746 242 510 1.537 1.225 1.265 1.107
2025/202629.122 2.382 1.385 2.438 3.786 3.813 1.830 2.994 1.538 2.802 3.242 1.652 1.260
Totale 72.308